Long‐term efficacy and safety of bexarotene for Japanese patients with cutaneous T‐cell lymphoma: The results of a phase 2 study (B‐1201)

The present study (B‐1201 clinical trial) was conducted as a multicenter, open‐label, single‐arm phase II study to evaluate the long‐term safety, tolerability and efficacy of bexarotene. This study enrolled 10 Japanese adults aged more than 20 years with cutaneous T‐cell lymphoma (CTCL) who complete...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamada, Toshihisa, Tokura, Yoshiki, Sugaya, Makoto, Ohtsuka, Mikio, Tsuboi, Ryoji, Nagatani, Tetsuo, Kiyohara, Eiji, Tani, Mamori, Setoyama, Mitsuru, Matsushita, Shigeto, Kawai, Kazuhiro, Yonekura, Kentaro, Saida, Toshiaki, Iwatsuki, Keiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899816/
https://www.ncbi.nlm.nih.gov/pubmed/31090237
http://dx.doi.org/10.1111/1346-8138.14923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899816/
https://www.ncbi.nlm.nih.gov/pubmed/31090237
http://dx.doi.org/10.1111/1346-8138.14923

Ejemplares similares